Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 12/20 | 0.33 |
| ▸ | JAK2 | O60674 | 4/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3781770 | 1.00 | MAPK1 (0.33) | MAPK1JAK2P2RX7CDK4CDK2 | |
| SCHEMBL3770357 | 0.89 | RAPGEF4 (0.30) | — | |
| SCHEMBL3433367 | 0.89 | RAPGEF4 (0.30) | — | |
| SCHEMBL3781782 | 0.86 | MAPK1 (0.33) | MAPK1P2RX7CDK4CDK2 | |
| SCHEMBL3435660 | 0.85 | JAK2 (0.37) | MAPK1JAK2P2RX7CDK4CDK2 | |
| SCHEMBL3783059 | 0.85 | JAK2 (0.37) | MAPK1JAK2P2RX7CDK4CDK2 | |
| SCHEMBL10009558 | 0.82 | MAPK1 (0.34) | MAPK1P2RX7 | |
| SCHEMBL27982242 | 0.82 | MAPK1 (0.34) | MAPK1P2RX7 | |
| SCHEMBL10009796 | 0.82 | MAPK1 (0.34) | MAPK1P2RX7 | |
| SCHEMBL3777850 | 0.81 | GSK3B (0.46) | JAK2CDK4CDK2GSK3BCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2257535-A1 | TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | Janssen Pharmaceutica N.V. (BE) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009115547-A1 | TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2009-09-24 | — | — | WO | disclosed |